SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-064217
Filing Date
2018-12-12
Accepted
2018-12-12 13:15:38
Documents
1
Period of Report
2018-12-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv508813_form4.html 4  
1 FORM 4 tv508813_form4.xml 4 5508
  Complete submission text file 0001144204-18-064217.txt   6982
Mailing Address C/O RETROPHIN INC., 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address
Paley Jeffrey (Reporting) CIK: 0001595327 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38114 | Film No.: 181230563

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations